Add BrightSurf on Google Email

International Molecular Tumor Board explores personalized treatment strategies for a patient with multiple primary cancers

A new precision oncology paper presents a case of a 48-year-old woman with multiple primary cancers, including breast cancer, basal cell carcinoma, ovarian carcinoma, colon cancer, and small bowel adenocarcinoma. The study demonstrates how an international molecular tumor board developed personalized treatment recommendations based on ...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateJul 22, 2026

New study reveals editorial trends at top science journals

A new analysis of over 110,000 papers submitted to Science and Science Advances reveals Western scientists, larger teams, and top-ranked universities have slight advantages in acceptance rates. The study provides insights into editorial dynamics and outcome disparities, shedding light on the peer review process.

SourceUniversity of Vermont·JournalScience Advances·TypeData/statistical analysis·DateJul 15, 2026

Rare cervical tumor highlights importance of accurate diagnosis in women with persistent menorrhagia and pelvic pain

A rare case report highlights the challenges of diagnosing cervical angioleiomyoma, a benign tumor presenting symptoms similar to those of common gynecological conditions. The study describes a successful surgical excision and excellent clinical outcome for a young woman with persistent heavy menstrual bleeding and pelvic pain.

SourceImpact Journals LLC·JournalOncoscience·DateJul 15, 2026

PLOS responds to Office of Management and Budget (OMB) proposed rule

The proposed OMB rule change would fundamentally alter how federal research funding is allocated in the US, compromising research independence and restricting international collaboration. PLOS argues that costs linked to making research available should be assessed against public and economic value, rather than being unallowable.

SourcePLOS·DateJul 14, 2026

Comprehensive individual-patient analysis clarifies life expectancy across rare progeria disorders

A comprehensive systematic review clarifies life expectancy across rare progeria disorders, revealing striking differences among subtypes. The analysis demonstrates that patients with Hutchinson-Gilford progeria syndrome have a median survival of 16 years, while those with mandibuloacral dysplasia type B have a median survival of 37 ye...

SourceImpact Journals LLC·JournalAging-US·TypeSystematic review·DateJul 6, 2026

Experimental compounds trigger cancer cell death in KRAS-driven pancreatic cancer

Researchers investigated polyisoprenylated cysteinyl amide inhibitors (PCAIs) for their anticancer effects on pancreatic cancer cells with KRAS mutations. The compounds demonstrated strong activity against cell survival, migration, and invasion pathways. PCAI treatment caused hyperactivation of MAPK and PI3K/AKT pathways, leading to ox...

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateJun 8, 2026

AI can mass-produce finance research papers indistinguishable from human work

A new study shows AI can generate hundreds of convincing finance research papers efficiently, but also raises concerns about the potential impact on academic community and meaning of scientific discovery. The study demonstrates how AI can accelerate research paper production while highlighting areas for improvement in peer-review systems.

SourcePenn State·JournalJournal of Economic Literature·TypeComputational simulation/modeling·DateMay 28, 2026

Extending healthspan through public health and longevity medicine

The editorial highlights the growing importance of public health interventions to extend healthspan alongside lifespan. Key findings include the need for integrated strategies addressing environmental, metabolic, social, and behavioral exposures that accelerate biological aging and increase vulnerability to chronic disease. The authors...

SourceImpact Journals LLC·JournalAging-US·TypeCommentary/editorial·DateMay 20, 2026